Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Total Non-Current Liabilities: 2018-2025

Historic Total Non-Current Liabilities for Autolus Therapeutics (AUTL) over the last 6 years, with Sep 2025 value amounting to $396.0 million.

  • Autolus Therapeutics' Total Non-Current Liabilities rose 13.12% to $396.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $396.0 million, marking a year-over-year increase of 13.12%. This contributed to the annual value of $355.0 million for FY2024, which is 34.69% up from last year.
  • As of Q3 2025, Autolus Therapeutics' Total Non-Current Liabilities stood at $396.0 million, which was up 5.88% from $374.0 million recorded in Q2 2025.
  • Over the past 5 years, Autolus Therapeutics' Total Non-Current Liabilities peaked at $396.0 million during Q3 2025, and registered a low of -$631.0 million during Q2 2021.
  • Moreover, its 3-year median value for Total Non-Current Liabilities was $325.4 million (2024), whereas its average is $308.9 million.
  • In the last 5 years, Autolus Therapeutics' Total Non-Current Liabilities tumbled by 222.93% in 2021 and then soared by 123.01% in 2023.
  • Autolus Therapeutics' Total Non-Current Liabilities (Quarterly) stood at $92.1 million in 2021, then skyrocketed by 107.88% to $191.5 million in 2022, then surged by 37.64% to $263.6 million in 2023, then spiked by 34.69% to $355.0 million in 2024, then climbed by 13.12% to $396.0 million in 2025.
  • Its Total Non-Current Liabilities stands at $396.0 million for Q3 2025, versus $374.0 million for Q2 2025 and $374.8 million for Q1 2025.